GEFITINIB (ZD1839-'IRESSA') AS SALVAGE THERAPY IN PRETREATED PATIENTS WITH ADVANCED NON-SMALL-CELL LUNG CANCER (NSCLC). FINAL DATA FROM A COMPASSIONATE USE PROGRAM
ANNALS OF ONCOLOGY(2004)
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要
ANNALS OF ONCOLOGY(2004)